Koyfin Home > Directory > Health Care > Bristol-Myers Squibb Company > EBIT

Bristol-Myers Squibb Company EBIT Chart (BMY)

Bristol-Myers Squibb Company annual/quarterly EBIT from 2010 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Bristol-Myers Squibb Company EBIT for the quarter ending June 06, 2020 was $1,958m a 7.56% increase of 148m year over year
  • Bristol-Myers Squibb Company EBIT for the last 12 months ending June 06, 2020 was $7,561m a 5.18% increase of 392m year over year
  • Bristol-Myers Squibb Company Annual EBIT for 2019 was $7,064m a 9.19% increase of 649m from 2018
  • Bristol-Myers Squibb Company Annual EBIT for 2018 was $6,415m a 37.96% increase of 2,435m from 2017
  • Bristol-Myers Squibb Company Annual EBIT for 2017 was $3,980m a -30.33% decrease of -1,207m from 2016
Other Income Statement Metrics:
  • Bristol-Myers Squibb Company EBITDA for the quarter ending December 12, 2018 was $1,907m a 15.52% increase of 296m year over year
  • Bristol-Myers Squibb Company Net Income for the quarter ending December 12, 2018 was $1,192m a -24.66% decrease of -294m year over year
  • Bristol-Myers Squibb Company Total Revenue for the quarter ending December 12, 2018 was $5,973m a 13.06% increase of 780m year over year
View Chart On Koyfin

Quarterly BMY EBIT Data

06/2020$1,958m
03/2020$2,360m
12/2019$1,388m
09/2019$1,810m
06/2019$2,077m
03/2019$1,787m
12/2018$1,495m
09/2018$1,728m
06/2018$1,677m
03/2018$1,515m

Annual BMY EBIT Data

2019$7,064m
2018$6,415m
2017$3,980m
2016$5,187m
2015$3,867m
2014$3,468m
2013$2,905m
2012$4,447m
2011$6,986m
2010$6,268m